Issue 6 – June 2017
Media Coverage
EMOTION
“Project EMOTION: Creating HIV Prevention Products that Fit into Women’s Lives.” USAID Global Health Newsletter. May 2017.
GEMS
“Future technologies for monitoring HIV drug resistance and cure.” Current Opinion in HIV & AIDS. March 2017, Vol 12, Issue 2, p 182-189.
-
OPTIONS – June 2017
The OPTIONS Consortium objective is to develop a streamlined, adaptable product delivery platform for current and future ARV-based HIV prevention options, with a particular focus on women.
- Kenya launches oral PrEP and continues work on communications strategy.
- OPTIONS holds modeling validation workshop in Kenya.
- Zimbabwe continues to lay groundwork for oral PrEP rollout.
- South Africa develops materials for continued oral PrEP rollout.
- OPTIONS begins implementation science activities.
- New resources added to PrEPWatch.
-
POWER – June 2017
POWER develops cost-effective and scalable models for implementation of ARV-based HIV prevention products for women.
- Mental models community surveys completed.
- Training for POWER’s PrEP delivery cohort completed in Cape Town, Johannesburg, and Kisumu.
- Site activation scheduled.
- My PrEP decision support tool undergoes cognitive testing.
-
EMOTION – June 2017
EMOTION increases uptake and correct and consistent use of ARV-based HIV prevention products by women at high risk of HIV infection using an end-user centered strategy.
- Project VOGUE underway.
Read More > -
CHARISMA – June 2017
CHARISMA supports efforts to: increase women’s agency to safely use ARV-based HIV prevention, to engage male partners in HIV prevention, and to overcome harmful gender norms and reduce intimate partner violence (IPV).
- Clinic- and community-based interventions continue.
- Intervention evaluations and reporting planned.
-
GEMS – June 2017
GEMS informs policies and defines programmatic considerations related to use of ARV-based HIV prevention products and risk of resistance.
- Genital swabs testing begins and assay development is underway.
- Oral PrEP modeling completed.
- Collaboration in Kenya continues.
- Resources being developed for training and M&E.
Issue 5 – February 2017
Media Coverage
OPTIONS
“Aid groups grapple with stigmatization in HIV prophylaxis roll-out.” Devex.com. 18 Nov 2016.
“Is the HIV prevention pill a ‘magic bullet’?” Mail & Guardian Bhekisisa Centre for Health Journalism. 30 Nov 2016.
“35 years into the AIDS epidemic, it’s an opportune but precarious time.” Devex.com. 1 Dec 2016.
“Opinion: 3 questions for rolling out the next generation of HIV prevention.” Devex.com. 1 Dec 2016.
“Thank God for PrEP: HIV Prevention Medicine Saving Lives.” Women Deliver’s Respecting Girls’ and Women’s Sexual Health and Rights! 9 Feb 2017.
-
OPTIONS – February 2017
The OPTIONS Consortium objective is to develop a streamlined, adaptable product delivery platform for current and future ARV-based HIV prevention options, with a particular focus on women.
- Government of Kenya ramps up oral PrEP launch.
- Zimbabwe lays groundwork for oral PrEP rollout.
- South Africa develops materials for continued oral PrEP rollout.
- South Africa offers refresher and new site training for oral PrEP program.
- Rollout scenario analyses completed for Kenya and Zimbabwe.
- Provider oral PrEP KAP landscape analysis finalized.
- Enhancements made and resources added to PrEPWatch.
- Blogs developed to share oral PrEP introduction experiences.
-
POWER – February 2017
POWER develops cost-effective and scalable models for implementation of ARV-based HIV prevention products for women.
- POWER formative report finalized.
- Community survey about oral PrEP underway.
- POWER open label oral PrEP cohort launch scheduled.
- Pre-testing of oral PrEP decision support tool initiated.
-
EMOTION – February 2017
EMOTION increases uptake and correct and consistent use of ARV-based HIV prevention products by women at high risk of HIV infection using an end-user centered strategy.
- Pilot messaging study completed.
- Socio-behavioral study underway.
-
CHARISMA – February 2017
CHARISMA supports efforts to: increase women’s agency to safely use ARV-based HIV prevention, to engage male partners in HIV prevention, and to overcome harmful gender norms and reduce intimate partner violence (IPV).
- Clinic-based intervention launched.
- Community-based intervention continues.
- Intervention evaluations and reporting planned.
-
GEMS – February 2017
GEMS informs policies and defines programmatic considerations related to use of ARV-based HIV prevention products and risk of resistance.
- Genital swabs testing begins and assay development is underway.
- Initial oral PrEP modeling completed.
- Collaboration in Kenya and Namibia continues.